EUR/USD 1.13761
-0.086%
Gold 4016.86
-0.289%
Oil 83.306
6.353%
USD/JPY 163.785
-0.046%
GBP/USD 1.32815
-0.049%
GBP/JPY 217.536
-0.081%
Browse More
  • English
  • 简体中文
  • 繁體中文
  • Tiếng Việt
  • ไทย
  • Indonesia
Subscribe
Real-time News
July 29th - Despite some speculation that the Federal Reserve might unexpectedly raise interest rates on Wednesday, Fundstrat Global Advisors market strategist Tom Lee believes this is unlikely, primarily based on recent progress on inflation. The latest inflation data shows that housing costs and other key components are slowing, giving the Fed room to keep rates unchanged. Therefore, it would be surprising if the Fed, which always emphasizes data collection, concluded that inflationary pressures remain strong based solely on surface observations. Admittedly, inflation has not yet returned to 2%, but the impact of tariffs and rising oil prices are distorting these figures. However, the Fed may consider further reducing its asset holdings on its balance sheet.TSMC (TSM.N): Raw material supply is normal.On July 29th, CSPC Pharmaceutical Group (01093.HK) announced in Hong Kong that its Phase II clinical trial (SYH2062-003) for the treatment of essential hypertension in adults, developed by the Group, has been officially launched at its first center in China. This product specifically silences the angiotensinogen (AGT) gene, inhibits the expression of the corresponding protein, and alleviates excessive activation of the renin-angiotensin system (RAAS), thereby exerting an effective pathway inhibition and long-term blood pressure control effect.On July 29, CSPC Pharmaceutical Group (01093.HK) announced in Hong Kong that CRB-701 (SYS6002), which the Group licensed to Corbus Pharmaceuticals, Inc. for development, has been approved by the U.S. Food and Drug Administration to initiate a registration clinical trial (trial code: TEMPO-1) for second-line treatment of oropharyngeal squamous cell carcinoma.Italian oil company Eni: Refineries will operate at maximum capacity in the third quarter.

In Colombia, natural gas consumption has outpaced production

Charlie Brooks

Jun 28, 2022 11:31


According to our most recent Colombia Country Analysis Brief, Colombia imported 14,2 billion cubic feet (Bcf) of natural gas to help meet its natural gas demand for electricity in 2020, when a drop in hydroelectric power was caused by drought.


In 2020, hydroelectricity will contribute to around 65% of Colombia's electrical generation, down from nearly 80% in earlier years. Since hydropower is Colombia's principal energy source, droughts may have a significant effect on the country's electrical producing mix.


The bulk of natural gas used in Colombia is produced domestically and employed to create electricity. In recent years, imports have progressively bridged the gap between domestic natural gas production and domestic demand. In 2020, Colombia produced 399 Bcf of dry natural gas, while domestic consumption was 413 Bcf.


Concerns over the reliability of the nation's electricity supply prompted the Colombian government to approve the Sociedad Portuaria El Cayao (SPEC) LNG import plant in November 2014. The facility started operations in November 2016. The administration has since proposed the Pacific Regasification LNG terminal as the nation's second LNG import plant.


EPM is currently developing the new hydroelectric dam project Ituango. The first of eight 300-megawatt generating units will commence operating in the second part of 2022. The whole project will have a capacity of 2.4 gigawatts when it is finished in 2025. If completed, the Ituango project would be the largest hydroelectric power plant in Colombia in terms of generating capacity. In 2020, the installed electrical production capacity of Colombia was 17 gigawatts.

Suggestion